pantoprazole has been researched along with lonazolac in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Büdingen, C; Fahr, S; Kinder, B; Koske, M; Simon, WA | 1 |
1 other study(ies) available for pantoprazole and lonazolac
Article | Year |
---|---|
The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; 7-Alkoxycoumarin O-Dealkylase; Adenosine Triphosphatases; Animals; Benzimidazoles; Biotransformation; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Ethylmorphine-N-Demethylase; Female; H(+)-K(+)-Exchanging ATPase; Kinetics; Lansoprazole; Liver; Omeprazole; Pantoprazole; Pyrazoles; Rats; Rats, Inbred Strains; Sulfoxides | 1991 |